News - Université Laval researchers have developed a highly effective method for converting CO2 into methanol, which can be used as a low-emissions fuel for vehicles. The team led by Professor Frédéric-Georges Fontaine presents the details of this discovery in the latest issue of the Journal of the American Chemical Society.
News - TD Economics’ latest Quarterly Economic Forecast reports that a soft landing in the housing market and slower consumer and government spending should be largely offset by stronger exports. As a result, Canadian economic growth will likely be modest, around 2% per year, during the 2013-14 period.
News - LeddarTech, creator of the unique and patented LeddarTM LED Detection and Ranging Technology, won big at this year’s Sensors Expo 2013. Held in Rosemont, IL, USA, on June 5 and 6, the expo presented LeddarTech with its “Best of Sensors Expo 2013 Innovation Award” for its new LeddarTM Sensor Evaluation Kit, which was launched on-site during the show.
News - Portneuf is a picnic waiting to happen. The Quebec region has park benches with mesmerizing views of the St. Lawrence River and lots of fixings for the food basket. A new tourism trail, the Gourmet Route, a.k.a. Le Parcours gourmand, has created a movable feast along a stretch of 125 kilometres featuring more than 50 stops in and around Quebec City.
News - TSO3 announces that while it is pursuing the US regulatory approval for the STERIZONE® 125L+ Sterilizer and continuing commercial negotiations on a non-exclusive basis, TSO3 has initiated a process to assess the range of strategic alternatives available to the Company, as a means to maximize shareholder value once regulatory clearance has been achieved. The purpose of this process is to evaluate the options available to the Company, by assessing the interest for the products, technology and development opportunities that TSO3 provides. TSO3 may ultimately determine that its current business plan is the best means to enhance shareholder value.
News - Medicago announces it was granted a patent from the European Patent Office (EPO) providing Medicago the exclusive rights to produce influenza VLPs in plants. Patent Number 2173886, titled "Influenza virus-like particles (VLPs) comprising hemagglutinin produced within a plant", will provide patent coverage for Medicago in Europe through July 2028. The EP 2173886 patent was originally filed on July 11, 2008, and the grant decision is scheduled to be published in the European Patent Bulletin on June 26, 2013.
News - Keeping up with chicken’s run has been a challenge for producers, and it’s what led Lévis-based Exceldor to spend $31 million on a new, state-of-the-art production plant in St-Bruno-de-Montarville that opened this spring.
News - Over the course of the next few weeks, construction will begin on the largest Internet data centre ever built in Quebec City. 4Degrés, which will be located in the Quebec Metro High Tech Park, is the only centre to benefit from a 14.2 megawatt power supply agreement for a single strategic block signed with Hydro-Québec, enabling it to attain the Tier III level of security. Martin Bouchard, founder of Copernic and co-founder of Coveo, is at the helm of this unique project, which guarantees the secure housing of computer servers in a colocation facility.
News - Medicago announces it has received clearance byHealth Canada to initiate its Phase II dose-sparing clinical trial for an H5N1 Avian Influenza VLP vaccine candidate. All clinical lots have been produced and the trial will commence with interim results expected in the summer of 2013.
News - Construction is underway in the St. Roch neighbourhood of Quebec City on a six-storey condominium development that incorporates cross-laminated timber (CLT) panels. The District 3 project is believed to be the tallest multi-family residential structure constructed of “massive” timber in the province and possibly North America.